Showing 1 - 10 results of 10 for search '"Cancer Communications"', query time: 0.04s Refine Results
  1. 1
    Discovery of a novel viroid‐like circular RNA in colorectal cancer

    Discovery of a novel viroid‐like circular RNA in colorectal cancer by Meini Wu, Wenliang Li, Ningzhu Hu, Changning Liu, Jianfang Li, Yanhan Li, Ning Xu, Jiandong Shi, Jing Sun, Jing Li, Yunzhang Hu

    Published 2025-01-01
    “…Cancer Communications…”
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Wnt/GSK‐3β mediates posttranslational modifications of FLYWCH1 to regulate intestinal epithelial function and tumorigenesis in the colon

    Wnt/GSK‐3β mediates posttranslational modifications of FLYWCH1 to regulate intestinal epithelial function and tumorigenesis in the colon by Sheema Almozyan, Roya Babaei‐Jadidi, Abrar Aljohani, Sepideh Youssefi, William Dalleywater, Prerna Kadam, Bradley Spencer‐Dene, Emad Rakha, Mohammad Ilyas, Abdolrahman Shams Nateri

    Published 2025-01-01
    “…Cancer Communications…”
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Anti‐tumor drug supervision in China from 2010 to 2024: the evolution and prospect of drug review standards

    Anti‐tumor drug supervision in China from 2010 to 2024: the evolution and prospect of drug review standards by Ling Tang, Yuanyuan Song, Hong Zhang, Ruimin Hao, Xin Tong, Xing Ai, Jun Ma, Zhimin Yang

    Published 2025-01-01
    “…Cancer Communications…”
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Tumor derived cell‐free nucleic acid upregulates programmed death‐ligand 1 expression in neutrophil via intracellular Toll‐like receptor signaling

    Tumor derived cell‐free nucleic acid upregulates programmed death‐ligand 1 expression in neutrophil via intracellular Toll‐like receptor signaling by Suguru Saito, Duo‐Yao Cao, Tomohiro Shibata, Yan Liu, Aoi Otagiri‐Hoshi, Xiaojiang Cui, Kenneth E. Bernstein

    Published 2025-01-01
    “…Cancer Communications…”
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Epigenomic exploration of disease status of EGFR‐mutated non‐small cell lung cancer using plasma cell‐free DNA hydroxymethylomes

    Epigenomic exploration of disease status of EGFR‐mutated non‐small cell lung cancer using plasma cell‐free DNA hydroxymethylomes by Yong Peng, Jason Karpus, Jyoti D. Patel, Everett E. Vokes, Marina Chiara Garassino, Kirsteen Lugtu, Zhou Zhang, Wei Zhang, Mengjie Chen, Chuan He, Christine M. Bestvina

    Published 2025-01-01
    “…Cancer Communications…”
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Ex vivo STAT3 phosphorylation in circulating immune cells: a novel biomarker for early cancer diagnosis and response to anti‐PD‐1 therapy

    Ex vivo STAT3 phosphorylation in circulating immune cells: a novel biomarker for early cancer diagnosis and response to anti‐PD‐1 therapy by Sung‐Woo Lee, Young Ju Kim, Saei Jeong, Kyung Na Rho, Jeong Eun Noh, Hee‐Ok Kim, Hyun‐Ju Cho, Yoo Duk Choi, Deok Hwan Yang, Eu Chang Hwang, Woo Kyun Bae, Sook Jung Yun, Ju Sik Yun, Cheol‐Kyu Park, In‐Jae Oh, Jae‐Ho Cho

    Published 2025-01-01
    “…Cancer Communications…”
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Effect of neutrophils on tumor immunity and immunotherapy resistance with underlying mechanisms

    Effect of neutrophils on tumor immunity and immunotherapy resistance with underlying mechanisms by Jiali Yao, Linlin Ji, Guang Wang, Jin Ding

    Published 2025-01-01
    “…Cancer Communications…”
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Targeting IL‐17A to manage immunotherapy‐induced toxicity in melanoma

    Targeting IL‐17A to manage immunotherapy‐induced toxicity in melanoma by Kai Huang

    Published 2025-01-01
    “…Cancer Communications…”
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    PTPN9 regulates HER3 phosphorylation during trastuzumab treatment and loss of PTPN9 is a potential biomarker for trastuzumab resistance in HER2 positive breast cancer

    PTPN9 regulates HER3 phosphorylation during trastuzumab treatment and loss of PTPN9 is a potential biomarker for trastuzumab resistance in HER2 positive breast cancer by Abul Azad, Maryam Arshad, Daniele Generali, Katharina Feldinger, Merel Gijsen, Carla Strina, Mariarosa Cappelletti, Daniele Andreis, Russell Leek, Syed Haider, Pirkko‐Liisa Kellokumpu‐Lehtinen, Ioannis Roxanis, Adrian Llewellyn Harris, Abeer Mahmoud Shaaban, Heikki Joensuu, Anthony Kong

    Published 2025-01-01
    “…Cancer Communications…”
    Get full text
    Article
    Save to List
    Saved in:
  10. 10
    FOXO1 or not FOXO1: that is the question

    FOXO1 or not FOXO1: that is the question by Maude Marchais, Marianne Mangeney

    Published 2025-01-01
    “…Cancer Communications…”
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: